{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:31:18Z","timestamp":1770492678742,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T00:00:00Z","timestamp":1307404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T00:00:00Z","timestamp":1307404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Our purpose was to investigate variation within the IL-32 promoter and gene, and susceptibility to and outcomes from infection associated acute lung injury (ALI).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Retrospective case-control study involving healthy individuals (controls) and patients (cases) with infection-associated ALI. Two hundred fifty-eight healthy normal controls and 251 patients with infection-associated ALI were used for comparison. The IL-32 promoter\/gene was sequenced in 52 healthy Caucasian individuals to identify single nucleotide polymorphisms (SNPs). Allelic discrimination was performed on 11 SNPs to determine differences between cases and controls and outcomes in patients with infection associated ALI.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Logistic and normal regression models were used to evaluate the associations with SNPs in cases and controls, and outcomes in patients with infection associated ALI. rs12934561, an intronic SNP, was found to be associated with risk for ALI in the case-control study and with more severe clinical course, as shown by increased time on the ventilator and the presence of fluid unresponsive hypotension. Further, it was found that rs12934561 has gender-specific effects and strongly interacts with other SNPs.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>A common IL-32 genotype, rs12934561, is associated with the risk of ALI as well as the need for prolonged mechanical ventilatory support. This finding suggests that IL-32 is not only involved in the initiating inflammatory and cellular events that result in ALI, but also participates in determining the severity of pulmonary dysfunction associated with ALI.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/cc10258","type":"journal-article","created":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T18:33:57Z","timestamp":1307471637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Association between IL-32 genotypes and outcome in infection-associated acute lung injury"],"prefix":"10.1186","volume":"15","author":[{"given":"John J","family":"Arcaroli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nianjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nengjun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,7]]},"reference":[{"key":"9535_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1001\/jama.1994.03510270072043","volume":"271","author":"AL Beal","year":"1994","unstructured":"Beal AL, Cerra FB: Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction.\n                           JAMA 1994, 271: 226-233. 10.1001\/jama.271.3.226","journal-title":"JAMA"},{"key":"9535_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00000658-199208000-00002","volume":"216","author":"EA Deitch","year":"1992","unstructured":"Deitch EA: Multiple organ failure. Pathophysiology and potential future therapy.\n                           Ann Surg 1992, 216: 117-134. 10.1097\/00000658-199208000-00002","journal-title":"Ann Surg"},{"key":"9535_CR3","first-page":"L1","volume":"276","author":"E Abraham","year":"1999","unstructured":"Abraham E, Kaneko DJ, Shenkar R: Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation.\n                           Am J Physiol 1999, 276: L1-8.","journal-title":"Am J Physiol"},{"key":"9535_CR4","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.4049\/jimmunol.157.4.1630","volume":"157","author":"TS Blackwell","year":"1996","unstructured":"Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW: In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation.\n                           J Immunol 1996, 157: 1630-1637.","journal-title":"J Immunol"},{"key":"9535_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0167-5699(95)80066-2","volume":"16","author":"MA Cassatella","year":"1995","unstructured":"Cassatella MA: The production of cytokines by polymorphonuclear neutrophils.\n                           Immunol Today 1995, 16: 21-26. 10.1016\/0167-5699(95)80066-2","journal-title":"Immunol Today"},{"key":"9535_CR6","first-page":"394","volume":"123","author":"R Faggioni","year":"1994","unstructured":"Faggioni R, Gatti S, Demitri MT, Delgado R, Echtenacher B, Gnocchi P, Heremans H, Ghezzi P: Role of xanthine oxidase and reactive oxygen intermediates in LPS- and TNF-induced pulmonary edema.\n                           J Lab Clin Med 1994, 123: 394-399.","journal-title":"J Lab Clin Med"},{"key":"9535_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1365-2249.1993.tb05924.x","volume":"91","author":"S Gatti","year":"1993","unstructured":"Gatti S, Faggioni R, Echtenacher B, Ghezzi P: Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality.\n                           Clin Exp Immunol 1993, 91: 456-461.","journal-title":"Clin Exp Immunol"},{"key":"9535_CR8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.4049\/jimmunol.160.2.1007","volume":"160","author":"MV Parsey","year":"1998","unstructured":"Parsey MV, Tuder RM, Abraham E: Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia.\n                           J Immunol 1998, 160: 1007-1013.","journal-title":"J Immunol"},{"key":"9535_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1165\/rcmb.F305","volume":"33","author":"MA Matthay","year":"2005","unstructured":"Matthay MA, Zimmerman GA: Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management.\n                           Am J Respir Cell Mol Biol 2005, 33: 319-327. 10.1165\/rcmb.F305","journal-title":"Am J Respir Cell Mol Biol"},{"key":"9535_CR10","first-page":"131","volume":"22","author":"SH Kim","year":"2005","unstructured":"Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA: Interleukin-32: a cytokine and inducer of TNFalpha.\n                           Immunity 2005, 22: 131-142.","journal-title":"Immunity"},{"key":"9535_CR11","doi-asserted-by":"publisher","first-page":"16309","DOI":"10.1073\/pnas.0508237102","volume":"102","author":"MG Netea","year":"2005","unstructured":"Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, Abraham E, Kim JM, Yoon DY, Dinarello CA, Kim SH: IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism.\n                           Proc Natl Acad Sci USA 2005, 102: 16309-16314. 10.1073\/pnas.0508237102","journal-title":"Proc Natl Acad Sci USA"},{"key":"9535_CR12","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1073\/pnas.0813334106","volume":"106","author":"CA Nold-Petry","year":"2009","unstructured":"Nold-Petry CA, Nold MF, Zepp JA, Kim SH, Voelkel NF, Dinarello CA: IL-32-dependent effects of IL-1beta on endothelial cell functions.\n                           Proc Natl Acad Sci USA 2009, 106: 3883-3888. 10.1073\/pnas.0813334106","journal-title":"Proc Natl Acad Sci USA"},{"key":"9535_CR13","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1164\/rccm.200804-646OC","volume":"178","author":"F Calabrese","year":"2008","unstructured":"Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P, Turato G, Lokar-Oliani K, Papi A, Zuin R, Sfriso P, Balestro E, Dinarello C, Saetta M: IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.\n                           Am J Respir Crit Care Med 2008, 178: 894-901. 10.1164\/rccm.200804-646OC","journal-title":"Am J Respir Crit Care Med"},{"key":"9535_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1164\/rccm.200903-0400OC","volume":"180","author":"C Sorrentino","year":"2009","unstructured":"Sorrentino C, Di Carlo E: Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype.\n                           Am J Respir Crit Care Med 2009, 180: 769-779. 10.1164\/rccm.200903-0400OC","journal-title":"Am J Respir Crit Care Med"},{"key":"9535_CR15","first-page":"1606","volume":"18","author":"EH Seo","year":"2008","unstructured":"Seo EH, Kang J, Kim KH, Cho MC, Lee S, Kim HJ, Kim JH, Kim EJ, Park DK, Kim SH, Choi YK, Kim JM, Hong JT, Yoon DY, Eun-Hee S, Kang J, Ki KH: Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining.\n                           J Microbiol Biotechnol 2008, 18: 1606-1612.","journal-title":"J Microbiol Biotechnol"},{"key":"9535_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1365-2249.2007.03439.x","volume":"149","author":"M Shioya","year":"2007","unstructured":"Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, Andoh A: Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.\n                           Clin Exp Immunol 2007, 149: 480-486. 10.1111\/j.1365-2249.2007.03439.x","journal-title":"Clin Exp Immunol"},{"key":"9535_CR17","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1007\/s00018-007-7186-8","volume":"64","author":"H Shoda","year":"2007","unstructured":"Shoda H, Fujio K, Yamamoto K: Rheumatoid arthritis and interleukin-32.\n                           Cell Mol Life Sci 2007, 64: 2671-2679. 10.1007\/s00018-007-7186-8","journal-title":"Cell Mol Life Sci"},{"key":"9535_CR18","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1073\/pnas.0511233103","volume":"103","author":"LA Joosten","year":"2006","unstructured":"Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB: IL-32, a proinflammatory cytokine in rheumatoid arthritis.\n                           Proc Natl Acad Sci USA 2006, 103: 3298-3303. 10.1073\/pnas.0511233103","journal-title":"Proc Natl Acad Sci USA"},{"key":"9535_CR19","first-page":"289","volume":"16","author":"N Cagnard","year":"2005","unstructured":"Cagnard N, Letourneur F, Essabbani A, Devauchelle V, Mistou S, Rapinat A, Decraene C, Fournier C, Chiocchia G: Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine\/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes.\n                           Eur Cytokine Netw 2005, 16: 289-292.","journal-title":"Eur Cytokine Netw"},{"key":"9535_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2567.2008.02917.x","volume":"126","author":"JD Choi","year":"2009","unstructured":"Choi JD, Bae SY, Hong JW, Azam T, Dinarello CA, Her E, Choi WS, Kim BK, Lee CK, Yoon DY, Kim SJ, Kim SY: Identification of the most active interleukin-32 isoform.\n                           Immunology 2009, 126: 535-542. 10.1111\/j.1365-2567.2008.02917.x","journal-title":"Immunology"},{"key":"9535_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa032193","volume":"351","author":"RG Brower","year":"2004","unstructured":"Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT: Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.\n                           N Engl J Med 2004, 351: 327-336.","journal-title":"N Engl J Med"},{"key":"9535_CR22","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1093\/hmg\/11.20.2463","volume":"11","author":"HJ Cordell","year":"2002","unstructured":"Cordell HJ: Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans.\n                           Hum Mol Genet 2002, 11: 2463-2468. 10.1093\/hmg\/11.20.2463","journal-title":"Hum Mol Genet"},{"key":"9535_CR23","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1534\/genetics.104.035857","volume":"169","author":"ZB Zeng","year":"2005","unstructured":"Zeng ZB, Wang T, Zou W: Modeling quantitative trait Loci and interpretation of models.\n                           Genetics 2005, 169: 1711-1725.","journal-title":"Genetics"},{"key":"9535_CR24","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nrg1916","volume":"7","author":"DJ Balding","year":"2006","unstructured":"Balding DJ: A tutorial on statistical methods for population association studies.\n                           Nat Rev Genet 2006, 7: 781-791. 10.1038\/nrg1916","journal-title":"Nat Rev Genet"},{"key":"9535_CR25","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1534\/genetics.108.099556","volume":"181","author":"N Yi","year":"2009","unstructured":"Yi N, Banerjee S: Hierarchical generalized linear models for multiple quantitative trait locus mapping.\n                           Genetics 2009, 181: 1101-1113. 10.1534\/genetics.108.099556","journal-title":"Genetics"},{"key":"9535_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1469-1809.2010.00605.x","volume":"75","author":"N Yi","year":"2011","unstructured":"Yi N, Kaklamani VG, Pasche B: Bayesian analysis of genetic interactions in case-control studies, with application to adiponectin genes and colorectal cancer risk.\n                           Ann Hum Genet 2011, 75: 90-104. 10.1111\/j.1469-1809.2010.00605.x","journal-title":"Ann Hum Genet"},{"key":"9535_CR27","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1214\/08-AOAS191","volume":"2","author":"A JA Gelman","year":"2008","unstructured":"Gelman A JA, Pittau MG, Su YS: A weakly informative default prior distribution for logistic and other regression models.\n                           Annals of Applied Statistics 2008, 2: 1360-1383. 10.1214\/08-AOAS191","journal-title":"Annals of Applied Statistics"},{"key":"9535_CR28","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/gepi.20417","volume":"33","author":"AS Allen","year":"2009","unstructured":"Allen AS, Satten GA: A novel haplotype-sharing approach for genome-wide case-control association studies implicates the calpastatin gene in Parkinson's disease.\n                           Genet Epidemiol 2009, 33: 657-667. 10.1002\/gepi.20417","journal-title":"Genet Epidemiol"},{"key":"9535_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cyto.2009.10.003","volume":"49","author":"J Hong","year":"2010","unstructured":"Hong J, Bae S, Kang Y, Yoon D, Bai X, Chan ED, Azam T, Dinarello CA, Lee S, Her E, Rhof G, Kim S: Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNF[alpha] and IL-1[beta].\n                           Cytokine 2010, 49: 171-176. 10.1016\/j.cyto.2009.10.003","journal-title":"Cytokine"},{"key":"9535_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2249.2009.03920.x","volume":"156","author":"HE Barksby","year":"2009","unstructured":"Barksby HE, Nile CJ, Jaedicke KM, Taylor JJ, Preshaw PM: Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide.\n                           Clin Exp Immunol 2009, 156: 479-487. 10.1111\/j.1365-2249.2009.03920.x","journal-title":"Clin Exp Immunol"},{"key":"9535_CR31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cyto.2009.03.007","volume":"46","author":"H Kobayashi","year":"2009","unstructured":"Kobayashi H, Lin PC: Molecular characterization of IL-32 in human endothelial cells.\n                           Cytokine 2009, 46: 351-358. 10.1016\/j.cyto.2009.03.007","journal-title":"Cytokine"},{"key":"9535_CR32","doi-asserted-by":"publisher","first-page":"iii61","DOI":"10.1136\/ard.2006.058511","volume":"65","author":"CA Dinarello","year":"2006","unstructured":"Dinarello CA, Kim SH: IL-32, a novel cytokine with a possible role in disease.\n                           Ann Rheum Dis 2006, 65: iii61-iii64. 10.1136\/ard.2006.058511","journal-title":"Ann Rheum Dis"},{"key":"9535_CR33","doi-asserted-by":"publisher","first-page":"e9458","DOI":"10.1371\/journal.pone.0009458","volume":"5","author":"H Kobayashi","year":"2010","unstructured":"Kobayashi H, Huang J, Ye F, Shyr Y, Blackwell TS, Lin PC: Interleukin-32\u03b2 propagates vascular inflammation and exacerbates sepsis in a mouse model.\n                           PLoS ONE 2010, 5: e9458. 10.1371\/journal.pone.0009458","journal-title":"PLoS ONE"},{"key":"9535_CR34","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.1097\/01.CCM.0000057843.47705.E8","volume":"31","author":"E Abraham","year":"2003","unstructured":"Abraham E: Neutrophils and acute lung injury.\n                           Crit Care Med 2003, 31: S195-199. 10.1097\/01.CCM.0000057843.47705.E8","journal-title":"Crit Care Med"},{"key":"9535_CR35","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/S0140-6736(07)60604-7","volume":"369","author":"AP Wheeler","year":"2007","unstructured":"Wheeler AP, Bernard GR: Acute lung injury and the acute respiratory distress syndrome: a clinical review.\n                           Lancet 2007, 369: 1553-1564. 10.1016\/S0140-6736(07)60604-7","journal-title":"Lancet"},{"key":"9535_CR36","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1056\/NEJM200005043421806","volume":"342","author":"LB Ware","year":"2000","unstructured":"Ware LB, Matthay MA: The acute respiratory distress syndrome.\n                           N Engl J Med 2000, 342: 1334-1349. 10.1056\/NEJM200005043421806","journal-title":"N Engl J Med"},{"key":"9535_CR37","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1164\/ajrccm\/145.5.1016","volume":"145","author":"PM Suter","year":"1992","unstructured":"Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM: High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis.\n                           Am Rev Respir Dis 1992, 145: 1016-1022.","journal-title":"Am Rev Respir Dis"},{"key":"9535_CR38","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/00003246-200103000-00029","volume":"29","author":"D Yoshinari","year":"2001","unstructured":"Yoshinari D, Takeyoshi I, Koibuchi Y, Matsumoto K, Kawashima Y, Koyama T, Ohwada S, Morishita Y: Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway.\n                           Crit Care Med 2001, 29: 628-634. 10.1097\/00003246-200103000-00029","journal-title":"Crit Care Med"},{"key":"9535_CR39","doi-asserted-by":"publisher","first-page":"L1267","DOI":"10.1152\/ajplung.00097.2006","volume":"291","author":"CD Coldren","year":"2006","unstructured":"Coldren CD, Nick JA, Poch KR, Woolum MD, Fouty BW, O'Brien JM, Gruber MP, Zamora MR, Svetkauskaite D, Richter DA, He Q, Park JS, Overdier KH, Abraham E, Geraci MW: Functional and genomic changes induced by alveolar transmigration in human neutrophils.\n                           Am J Physiol Lung Cell Mol Physiol 2006, 291: L1267-L1276. 10.1152\/ajplung.00097.2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"9535_CR40","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1164\/ajrccm.163.7.2009111","volume":"163","author":"NP O'Grady","year":"2001","unstructured":"O'Grady NP, Preas HL, Pugin J, Fiuza C, Tropea M, Reda D, Banks SM, Suffredini AF: Local inflammatory responses following bronchial endotoxin instillation in humans.\n                           Am J Respir Crit Care Med 2001, 163: 1591-1598.","journal-title":"Am J Respir Crit Care Med"},{"key":"9535_CR41","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1378\/chest.09-1484","volume":"137","author":"LB Ware","year":"2010","unstructured":"Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA: Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury.\n                           Chest 2010, 137: 288-296. 10.1378\/chest.09-1484","journal-title":"Chest"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc10258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc10258\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc10258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:27:39Z","timestamp":1728304059000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc10258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,7]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,6]]}},"alternative-id":["9535"],"URL":"https:\/\/doi.org\/10.1186\/cc10258","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,7]]},"assertion":[{"value":"21 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R138"}}